Policy Library Results:
Search results for: "fda"
162 results (showing 1 through 25)
The user facility must report the device to the manufacturer and the FDA. Adverse events shall be reported using the FDA Form 3500A and must contain the ...
ADDITIONAL RESOURCES: US Food and Drug Administration (FDA). (October 10, 2018). General Instructions for Completing the Biological Product Deviation ...
It is listed in a FDA rule as acceptable for pharmacy compounding. Note: The FDA is in the process of evaluating the bulk drug substances nominated for use in ...
To assure safe and efficacious reprocessing of single-use medical devices, the Food and Drug Administration (FDA) regulations will be strictly followed: All ...
To assure safe and efficacious reprocessing of single-use medical devices, the Food and Drug Administration (FDA) regulations will be strictly followed: All ...
shall ensure that only Food and Drug Administration (FDA) approved pharmaceuticals and health devices, certified manufactured equipment and qualified ...
shall ensure that only Food and Drug Administration (FDA) approved pharmaceuticals and health devices, certified manufactured equipment and qualified ...
The facility must also send a copy of the report to the FDA in the case of a death. Serious illness or injury as defined by the act is an illness or injury that is life ...
shall report the diversion to local law enforcement, DEA and the FDA as applicable. REGULATORY AGENCY CONTACT INFORMATION: ...
shall report the diversion to local law enforcement, DEA and the FDA as applicable. REGULATORY AGENCY CONTACT INFORMATION: ...
When Pharmacy Services receives information about a medication recall or discontinuation by the manufacturer or the FDA for safety reasons, all individuals ...
Only medications approved by the FDA for delivery into the spinal fluid shall be administered to patients. Medications approved for intrathecal medication ...
REFERENCES: US Food and Drug Administration (FDA). (September 27, 2018). Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). Retrieved ...
REFERENCES: US Food and Drug Administration (FDA). (September 27, 2018). Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). Retrieved ...
REFERENCES: US Food and Drug Administration (FDA). (September 27, 2018). Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). Retrieved ...
(organization name) shall comply with FDA regulations pertaining to blood safety issues in the areas of testing and quarantining of infectious blood and blood ...
(November 14, 2018). Use Caution with Implanted Pumps for Intrathecal Administration of Medicines for Pain Management: FDA Safety Communication.
... 7 DEPARTMENT: AMBULATORY SURGICAL CENTER EFFECTIVE: APPROVED BY: REVISED: DEFINITIONS: According to the FDA, an adverse event is any ...
DEFINITIONS: According to the FDA, an adverse event is any undesirable experience associated with the use of a medical product in a patient. The event is ...
DEFINITIONS: According to the FDA, an adverse event is any undesirable experience associated with the use of a medical product in a patient. The event is ...
DEFINITIONS: According to the FDA, an adverse event is any undesirable experience associated with the use of a medical product in a patient. The event is ...
... manufacturer (required by the Food and Drug Administration [FDA]). All documentation required shall be completed at the time of the implantation/ explanation.
... manufacturer (required by the Food and Drug Administration [FDA]). All documentation required shall be completed at the time of the implantation/ explanation.
This organization shall ensure that disinfectants used are compatible with and US Food and Drug Administration (FDA) approved high-level disinfectants.
Supplier registration status with the FDA shall be checked annually at http://www. fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformat ...
Previous Page Next Page